RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and safety of the novel dipeptidyl peptidase-4 inhibitor gemigliptin in the management of type 2 diabetes: a meta-analysis

Efficacy and safety of the novel dipeptidyl peptidase-4 inhibitor gemigliptin in the management of type 2 diabetes: a meta-analysis

Add to Collection
Systematic Review and Meta Analysis D Dutta, A Agarwal, I Maisnam… - Endocrinology and …, 2021 - synapse.koreamed.org

Chapter : Section1
Journal Year : 2021
Cited by : 11.0

… across the globe, including South Korea, India, and several Central American and South … Grading of the results Overall grading of the evidence (certainty of the evidence) related to …..... Read More

Keywords : ["novel dipeptidyl inhibitor gemigliptin", "type diabetes", "safety", "metaanalysis", "management", "efficacy"]
PubMed Link : https://synapse.koreamed.org/articles/1516079038
Google Scholar Link : https://scholar.google.com/scholar?cites=4562615753107851468&as_sdt=2005&sciodt=0,5&hl=en&num=20